A clinical trial for developing pain scale

A Clinical Trial to Collect the Biosignal data for Pain Scale Algorithm in Volunteer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001808

Enrollment

Registered

2016-02-11

Start date

2014-09-26

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Medical Device : -Cross over design -Pain stimulus is applied on the flat surface of tibia 15 cm below the patella using an algometer, and the stimulus is released when the volunteer complains o

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Volunteer who consented to participate in the trial

Exclusion criteria

Exclusion criteria: -Any disease that affects autonomic nervous system (diabetes mellitus, catecholamine secreting tumor, depression etc.) -Any disease that can induce spontaneous pain (rheumatoid arthritis, osteoarthritis, neuropathic pain inducing disease such as herniation of intervertebral disc and spinal stenosis), myopathic pain, or other chronic pain disease -Blind person or other ophthalmic disease -Arrhythmia or cardiac disease -Cerebrovascular disease or prior brain surgery -Epilepsy or history of psychosis -Long term administration of sedatives -Pregnant or possibly pregnant -Patients who are considered by the investigator to be unsuitable to participate in the study for any other reason not mentioned in the inclusion and exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Change of pain indicators before and after infusion of remifentanil and normal saline when pain stimulus is not given	—

Secondary

Measure	Time frame
Quantify the response of pain indicators;Adverse events	—

Countries

Korea, Republic of

Contacts

Public ContactByung-Moon Choi

Asan Medical Center

rios76@hanmail.net

Outcome results